The Basque Venture Capital Company Talde opens a new fund to support investments from Europe to Latin America and vice versa.
Features of the new fund
The new fund, which has 100 million euros, expandable to 150 million euros, aims to promote internalisation, increased procurement and mergers between European and Latin American companies.
Investors in Talde's new fund
Several international investors are expected to be among its participants, as it is being promoted in different countries and geographic areas.
The Talde Group's investors in its projects have usually been national investors, although it has also had international investors such as the French Electricity Pension Fund and the European Investment Fund.
Talde investee companies
Talde invests in a wide range of sectors, with no restrictions on activity or location among its investees.
Thus, its portfolio includes food companies such as Palacescompanies in the health sector, such as Deltalabtechnology companies, such as VS anywhere, telecommunication companies, such as Neo Skyof services such as Meydis e.t.c
Talde's most recent transaction is the purchase of 90% from ÑamingS.L., a Biscayan company in the food sector, is the leading national brand in the sandwich sector. Ñaming is growing considerably, achieving a turnover of over 12 million euros last year, thus multiplying its turnover by three in 4 years.
Talde continues to invest in companies with a clear innovative profile and in companies that are committed to implementing new technologies that facilitate the day-to-day life of society. Proof of this is that several of its investees have been recognised with awards related to innovation, such as Biopolis, a TALDE investee company, which was awarded the prize for Innovation in Health and Food awarded by the Universidad Católica San Antonio de Murcia in September 2013, or the prize for Innovation in Health and Food awarded by the Universidad Católica San Antonio de Murcia in September 2013, or the prize for Innovation in Health and Food awarded by the Universidad Católica San Antonio de Murcia in September 2013. Neos Surgery which was recognised by the National Innovation Company (ENISA) for its 'innovative approach' and included in the list of success stories.
Other posts that may interest you
The 74% of venture capital operations and venture capital is in 2013 were targeted at SMEs
EN 
ES